American Board of Psychiatry and Neurology

bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services

Retrieved on: 
Tuesday, September 19, 2023
Biotechnology, FDA, Other Health, Health, Radiology, Pharmaceutical, Oncology, Medical Devices, Surgery, Genetics, Clinical Trials, COPD, DNA, Fitzsimons Army Medical Center, American Board of Psychiatry and Neurology, College, Internal medicine, Louisiana State University, Marketing, Clinical Laboratory, SARS-CoV-2, CAP, Marie Cassidy, Pathology, Lung cancer, Lead, American Academy, College of American Pathologists, BIAF, Brooke Army Medical Center, Lung, Sale, Organization, American Board of Commissioners for Foreign Missions, STI, CLIA, Acquisition, Physician, Trustee, Psychiatry, American Academy of Neurology, Maria, American Board of Pathology, Medical imaging, Nursing, Neurology

bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the acquisition of the laboratory assets of Village Oaks Pathology Services, P.A., d/b/a Precision Pathology Services, a clinical laboratory accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.

Key Points: 
  • bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces the acquisition of the laboratory assets of Village Oaks Pathology Services, P.A., d/b/a Precision Pathology Services, a clinical laboratory accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.
  • The laboratory assets are being acquired by a new wholly owned subsidiary of bioAffinity Technologies, Precision Pathology Laboratory Services, LLC (PPLS).
  • Precision Pathology provides pathology services to physicians practicing in a variety of outpatient settings and has offered bioAffinity Technologies’ CyPath® Lung as a laboratory developed test for the detection of early-stage lung cancer.
  • In addition to CyPath® Lung, Precision Pathology offers a range of laboratory services including respiratory testing for SARS-CoV-2 and influenza, anatomic pathology, morphological stains, histological services, DNA extractions, STI testing, and women’s and men’s health testing.

Anavex Announces Appointment of Dr. Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board

Retrieved on: 
Tuesday, September 12, 2023
Memory, American Board of Psychiatry and Neurology, Central nervous system, University, Therapy, Sabbagh, Baylor University, Rett syndrome, Coronavirus Scientific Advisory Board, American Academy, University of Arizona College of Medicine – Phoenix, Doctor of Philosophy, CNS, Barrow Neurological Institute, American Board of Commissioners for Foreign Missions, DSM-IV codes, Journal, MD, Patient, Psychiatry, Baylor College of Medicine, Diagnosis, Research, American Academy of Neurology, Pharmaceutical industry, Dementia, Neurology

Prof. Dr. Marwan Sabbagh, MD, is a behavioral neurologist in the Alzheimer’s and Memory Disorders Program at Barrow Neurological Institute.

Key Points: 
  • Prof. Dr. Marwan Sabbagh, MD, is a behavioral neurologist in the Alzheimer’s and Memory Disorders Program at Barrow Neurological Institute.
  • He is also a professor and the Vice Chair of Research in the Institute’s Department of Neurology.
  • He is board certified in neurology by the American Board of Psychiatry and Neurology.
  • “I’m excited to join Anavex’s Scientific Advisory Board at this time of important progress of the Company,” said Professor Dr. Sabbagh.

The Inner Circle Acknowledges, Arun Kumar Sherma as a Pinnacle Life Member for his contributions to the field of Internal Medicine

Retrieved on: 
Monday, August 14, 2023
Medical degree, Medical school, Society, American Board of Psychiatry and Neurology, University, Education, Wayne State University, Internal medicine, Physician, Spinal cord, American Board of Internal Medicine, ABIM, ASPCA, Stroke, Medicine, Brain, American Association of Neurological Surgeons, Disorder, Inner circle, Tulane University, American College of Physicians, American Board of Commissioners for Foreign Missions, Animal, Patient, School, ABPN, Nervous system, Psychiatry, American College, Injury, Society of Critical Care Medicine, Northwestern University, Critical Care Medicine (journal), Veterinary medicine, Science, Psychology, Neuroscience, Neurology

DETROIT, Aug. 14, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Arun Kumar Sherma is acknowledged as a Pinnacle Life Member for his contributions to the field of Internal Medicine.

Key Points: 
  • DETROIT, Aug. 14, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Arun Kumar Sherma is acknowledged as a Pinnacle Life Member for his contributions to the field of Internal Medicine.
  • Dr. Sherma pursued higher education at Northwestern University where he earned a Bachelor of Science in Psychology with a focus on Neuroscience.
  • He then attended the University of Cincinnati, School of Medicine where he received a Medical Degree.
  • The doctor completed a residency in internal medicine and neurology at Tulane University and a fellowship in neurocritical care at the University of Pennsylvania, Perelman School of Medicine in Philadelphia.

Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer

Retrieved on: 
Monday, June 12, 2023
Psychiatry, Translation, Geriatric psychiatry, MidOcean Partners, Healthcare Businesswomen's Association, Research and development, American Board of Psychiatry and Neurology, University, Therapy, Harvard T.H. Chan School of Public Health, CableACE Award, Pharmacokinetics, DSM-IV codes, Head, University of Pittsburgh Medical Center, Chemical & Engineering News, Department of Neurology, Xuanwu hospital, Harvard University, Engineering News-Record, Hospital of the University of Pennsylvania, Development, American Board of Commissioners for Foreign Missions, Science, Chemical substance, Public health, MD, Patient, ABPN, Nature Biotechnology, Hospital, UPMC, Research, FDA, Massachusetts General Hospital, Safety, News, CHDR, Pfizer, Pharmaceutical industry, Adult, Medicine, Ramipril, Neurology

BOSTON, June 12, 2023 /PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, today announced the appointment of Dr. Aaron Koenig as Chief Medical Officer. Dr. Koenig will oversee Delix's clinical development programs, team build-out, and broader development strategy as the company advances its psychoplastogen platform of novel disease-modifying therapeutics for serious psychiatric, neurological, and neurodegenerative disorders.

Key Points: 
  • BOSTON, June 12, 2023 /PRNewswire/ -- Delix Therapeutics (the "Company"), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, today announced the appointment of Dr. Aaron Koenig as Chief Medical Officer.
  • Dr. Koenig joins the company from Sage Therapeutics, where he served most recently as Vice President of Early Medical Science and helped design and oversee clinical-stage programs, including compounds targeting a range of neuropsychiatric and neurodegenerative and disorders.
  • "As Delix navigates its phase I trial for the novel compound DLX-001, Dr. Koenig's experience in early clinical development will be crucial to advancing our novel neuroplasticity-promoting therapeutics," said Delix Therapeutics Head of Research & Development Dr. Eliseo Salinas.
  • A non-hallucinogenic psychoplastogen, DLX-001 is the first of several psychoplastogens in the Delix platform to be approved for human trials.

The Inner Circle Acknowledges, Michelle Thorpe, MD, as a Pinnacle Life Member for her contributions to the field of Psychiatry

Retrieved on: 
Monday, May 8, 2023
American Board of Psychiatry and Neurology, Greystone Park Psychiatric Hospital, Multimedia, Private practice, Inner circle, Bentham Science Publishers, American Board of Commissioners for Foreign Missions, MD, Fellow, Physician, Montclair, Montclair State University, Ross University School of Medicine, ABPN, Russian–Syrian hospital bombing campaign, New Bridge Medical Center, Medical degree, Nursing, Child, Psychiatry, Neurology

PARAMUS, N.J., May 8, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Michelle Thorpe, MD, is acknowledged as a Pinnacle Life Member for her contributions to the field of Psychiatry.

Key Points: 
  • PARAMUS, N.J., May 8, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Michelle Thorpe, MD, is acknowledged as a Pinnacle Life Member for her contributions to the field of Psychiatry.
  • She then attended Ross University School of Medicine where she completed a Medical Degree followed by a Psychiatry residency program at Bergen Regional Medical Center from 2008—2012.
  • Board-certified in Psychiatry and Child & Adolescent Psychiatry by the American Board of Psychiatry and Neurology (ABPN) and is considered an expert in psychiatry and neurology.
  • Dr. Thorpe notes that the ABPN is a nonprofit organization that certifies qualified physicians in the medical specialties of Psychiatry and Neurology.

Hidden River Announces New Leadership Team Members

Retrieved on: 
Wednesday, March 29, 2023
LCSW, Self-harm, Meadowview Psychiatric Hospital, American Board of Psychiatry and Neurology, Eating disorder, Francine Shapiro, Hidden, LCP, Parent, Professional, International Association, Woman, History, LMFT, Bentham Science Publishers, MS, Certification, American Board of Commissioners for Foreign Missions, Patient, CETP, Eating, Psychiatry, MSW, Neurology, Bariatric surgery, Family, Adolescence, Nightclub, Nursing, Water's Journey: The Hidden Rivers of Florida, Child, Supervisor, EMDR

CHESTER, N.J., March 28, 2023 /PRNewswire/ -- Hidden River, a residential eating disorder treatment center for girls and women ages 11 to 20, is proud to announce the new members of its leadership team.

Key Points: 
  • CHESTER, N.J., March 28, 2023 /PRNewswire/ -- Hidden River, a residential eating disorder treatment center for girls and women ages 11 to 20, is proud to announce the new members of its leadership team.
  • After over two decades in the eating disorder field, she is now leading the clinical team at Hidden River as they facilitate a specialized and comprehensive therapy program.
  • I am so grateful to be part of the Hidden River team and contributing in a meaningful way."
  • She joins the Hidden River team from her recent role as the Chief Medical Officer and Director of Child Services for Summit Oaks Hospital.

Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology

Retrieved on: 
Tuesday, February 28, 2023
Linda, Medicine, Loma Linda University Medical Center, Children's Specialized Hospital, School, Inner circle, Texas Medical Association, Patient, BPN, DSM-IV codes, American Board of Psychiatry and Neurology, American Medical Association, Internal medicine, Veterans Health Administration, James J. Peters VA Medical Center, American Academy of Neurology, American Association of Neuromuscular & Electrodiagnostic Medicine, Universidad del Noreste, Suite, Texas Institute for Genomic Medicine, Wilson N. Jones Regional Medical Center, Seizure, Rehabilitation hospital, EMG, Medical director, Fellow, Multimedia, American Board of Commissioners for Foreign Missions, ABPN, NCV, Electrodiagnostic medicine, Psychiatry, American Academy, Skiing, Veterinary medicine, Nursing, Pharmaceutical industry, Epilepsy, Neurology

SHERMAN, Texas, Feb. 28, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.

Key Points: 
  • SHERMAN, Texas, Feb. 28, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Jose A. Matus is acknowledged as a Top Pinnacle Professional for his contributions to the field of neurology.
  • Dr. Matus earned a medical degree from the School of Medicine at The Universidad de San Carlos de Guatemala in 1982.
  • He finished a Neurology Residency in 1995 at the Loma Linda University Medical Center in Loma Linda, CA.
  • Dr. Matus is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN).

AEON Biopharma to Host Key Opinion Leader Webinar on Past, Present, and Potential Future Treatments for Migraine on February 24th

Retrieved on: 
Tuesday, February 14, 2023
AEON, Dartmouth College, University of Washington School of Medicine, Weill Cornell Medicine, AHS, Publication, Dartmouth–Hitchcock Medical Center, Physician Payments Sunshine Act, Education, American Academy of Neurology, Research, City of London Finance Committee, Headache (journal), Editor-in-chief, Geisel School of Medicine, American Board of Commissioners for Foreign Missions, American Board of Psychiatry and Neurology, American Academy, Migraine, Psychiatry, Government in the Sunshine Act, KOL, Book, Yale College, Pharmaceutical industry, Headache, Neurology, MD

The event will highlight the differences between monotherapy and combination therapy in the context of migraine treatments.

Key Points: 
  • The event will highlight the differences between monotherapy and combination therapy in the context of migraine treatments.
  • Additionally, AEON’s leadership team will provide an update on clinical developments and the predicted timeline of future product development.
  • He is Director of the Dartmouth Headache Center in the Department of Neurology of Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
  • Dr. Tepper was Director of the Scottsdale Headache Symposium CME course of the American Headache Society from 2008 to 2020.

Katherine A. Daly, MD, is recognized by Continental Who's Who

Retrieved on: 
Monday, February 13, 2023
Woman, Adolescence, Physician, American Board of Pediatrics, American Medical Association, Continental, University of Minnesota Medical School, Differential diagnosis, University, Pediatrics, Neurology, Loyola, American Academy of Child and Adolescent Psychiatry, Daly, Epilepsy, American Board of Commissioners for Foreign Missions, American Board of Psychiatry and Neurology, Bentham Science Publishers, Panic disorder, Heart, American Academy, Psychiatry, MD, Dream, Medicine, Love, M Health Fairview, Trinity Health (Livonia, Michigan), American Psychiatric Association, Nursing, Child

WAYZATA, Minn., Feb. 13, 2023 /PRNewswire/ -- Katherine A. Daly, MD, is being recognized by Continental Who's Who as a Distinguished Medical Provider for her work in the Medical field.

Key Points: 
  • WAYZATA, Minn., Feb. 13, 2023 /PRNewswire/ -- Katherine A. Daly, MD, is being recognized by Continental Who's Who as a Distinguished Medical Provider for her work in the Medical field.
  • degree in 1992 from the University of Minnesota Medical School, followed by an internship in 1993 with Loyola Medicine MacNeal Hospital.
  • She finished fellowship training in child and adolescent psychiatry in 2000 at the University of Minnesota Medical School.
  • Lastly, she would love to continue to look at how pharmacological interventions can assist with family interactions and bonding.

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

Retrieved on: 
Wednesday, January 18, 2023
American Board of Psychiatry and Neurology, Protalix BioTherapeutics, Merck, Pharmacology, Mental health, CNS, American Board of Commissioners for Foreign Missions, Reunion, TSX, Head, Merck & Co., AstraZeneca, Patient, Clinical neuroscience, Neurology, University, Data analysis, Takeda Pharmaceutical Company, Pfizer, GSK, Psychiatry, Psychopharmacology, Pharmaceutical industry, GlaxoSmithKline, Takeda

TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or “the Company”), a biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, announced today that it has appointed Robert Alexander, M.D.

Key Points: 
  • TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or “the Company”), a biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, announced today that it has appointed Robert Alexander, M.D.
  • as the Company’s Chief Medical Officer, effective immediately.
  • Prior to Takeda, Dr. Alexander served as Chief Medical Officer, BioTherapeutics, at Pfizer, directing clinical pharmacology and statistics groups while simultaneously holding the position of Vice President and Head of the Clinical Neuroscience and Pain Research Unit at the company.
  • Second, the Company’s strong intellectual property position gives Reunion a significant competitive advantage over others in the space,” added Dr. Alexander.